4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-19-032833
Director sold 10,000 shares at $120.00 ($1,200,000)
- Director acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Wigzell Hans Lennart Rudolf · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-23 | Exercise or conversion : show line 1 in the form | +10,000 | $7.80 | $78,000 | 21,717 | D |
| 2019-05-23 | Sale : show line 2 in the form | −10,000 | $120.00 | $1,200,000 | 11,717 | D |
| Open-market sales · 10,000 sh · avg $120.00 · $1,200,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-05-23 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −10,000 | $7.80 | 2020-06-08 | 10,000 | 0 | D |
Loading xslF345X03/doc4.xml…